Abpro Holdings, Inc Common Stock

ABP XNAS • BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

Historical Short Interest Share

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Market Cap

1.4M

Short interest (Feb 13)

1.7%

Net Short (Feb 20 ): 7.8%

Borrow Fee

353.54%

↑ 413.7%

Available Shares

↑ 1731.6%

Price Chart

Company Overview

Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms. The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with pharmaceutical and research institutions.

Company Info

Exchange: NASDAQ

Industry: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

CIK: 0001893219

Asset Type: CS

Market Data

Market Cap: $1,412,464

Employees: 6

Status: Active

Short Interest

Current Borrow Fee 353.54%

Range: 326.80% - 359.22%

Available Shares 0

Range: 0 - 75K

Recent Changes

Fee Change: ↓ 10.3%

Available Change: ↓ 86.0%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime